Systematic Review to Assess Glucagon-like Peptide-1 Therapy Efficacy in Heart Failure Across LVEF Spectrum
The Efficacy of Glucagon-like Peptide-1 Based Therapies in Heart Failure Across the Spectrum of Left Ventricular Ejection Fraction: A Systematic Review and Meta-Analysis
Abstract
Glucagon-like peptide-1 (GLP-1) based therapies demonstrate cardioprotective effects and reduce new-onset heart failure hospitalizations, prompting a systematic review of their efficacy in established heart failure across LVEF.